Pfizer Inc. PFE
28.67
0.26
0.92%
as of 25 Sep
- Market cap
- $161.7B
- P/E
- 37.7×
Follow PFE
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Pfizer Inc. (PFE) Return on equity
Pfizer Inc.'s return on equity over the twelve months to 30 June 2026 was 4.97%, down 3.9 percentage points from fiscal 2025 (8.87%). Over the past ten years it has ranged from 2.29% (fiscal 2023) to 36.2% (fiscal 2022); the current reading is higher than 18% of that period. That is below the Drug Manufacturers General industry median of 6.97% and above the Healthcare sector median of −32.0%.
Return on equity, annual
Annual
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 8.87% | (0.16) |
| FY2024 | 9.03% | 6.74 |
| FY2023 | 2.29% | (33.90) |
| FY2022 | 36.2% | 5.00 |
| FY2021 | 31.2% | 16.76 |
| FY2020 | 14.4% | (10.77) |
| FY2019 | 25.2% | 8.72 |
| FY2018 | 16.5% | (15.94) |
| FY2017 | 32.4% | 20.86 |
| FY2016 | 11.6% | 1.37 |
Against its own ten years
Low 2.29%
High 36.2%
Ten-year median
14.4%
Current reading's percentile
18
Return on equity against peers
| Company | Return on equity |
|---|---|
| AMGN Amgen Inc. compare | 91.5% |
| NVO Novo Nordisk A/S compare | 60.8% |
| BMY Bristol Myers Squibb Company compare | 46.6% |
| GSK GSK PLC Sponsored ADR compare | 30.7% |
| NVS Novartis AG compare | 30.4% |
| AZN AstraZeneca PLC compare | 22.0% |
| SNY Sanofi compare | 5.87% |
| PFE Pfizer Inc. | 4.97% |
| GILD Gilead Sciences, Inc. compare | −20.7% |
| Drug Manufacturers General industry median | 6.97% |
| Healthcare sector median | −32.0% |
| Market median | 1.76% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on PFE
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement